Nitazoxanide treatment for norovirus infection in solid organ transplant recipients

Clin Transplant. 2022 Mar;36(3):e14594. doi: 10.1111/ctr.14594. Epub 2022 Jan 20.

Affiliations

¹ NewYork-Presbyterian Hospital, Department of Pharmacy, New York, New York, USA.
² Department of Pharmacy Practice, Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, New York, New York, USA.

PMID: 35032413
DOI: 10.1111/ctr.14594

No abstract available

Publication types

Letter

MeSH terms

Caliciviridae Infections* / drug therapy
Caliciviridae Infections* / etiology
Humans
Nitro Compounds
Organ Transplantation* / adverse effects
Thiazoles
Transplant Recipients

Substances

Nitro Compounds
Thiazoles
nitazoxanide